LDG Laboratories Dr. Gansauge

LDG Laboratories Dr. Gansauge is a German biotechnology company specializing in personalized cancer immunotherapy. The company focuses on the production and application of autologous dendritic cell vaccines, specifically its proprietary LANEX-DC therapy. By utilizing a patient's own immune cells to target tumor-specific antigens, LDG aims to provide non-toxic, individualized treatment options for various solid tumors. The laboratory operates under strict Good Manufacturing Practice (GMP) standards to ensure the quality and safety of its cell-based products. Their approach is primarily offered as a complementary treatment alongside standard oncological protocols. The company serves an international patient base seeking advanced therapeutic medicinal products (ATMPs) for difficult-to-treat cancers.